A detailed history of Nantahala Capital Management, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 700,000 shares of OCUL stock, worth $6.15 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
700,000
Previous 1,000,000 30.0%
Holding current value
$6.15 Million
Previous $6.84 Million 10.98%
% of portfolio
0.36%
Previous 0.46%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.45 - $9.23 $1.94 Million - $2.77 Million
-300,000 Reduced 30.0%
700,000 $6.09 Million
Q2 2024

Aug 14, 2024

BUY
$4.2 - $8.69 $4.2 Million - $8.69 Million
1,000,000 New
1,000,000 $6.84 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $676M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.